Tuberculosis history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mashal Awais, M.D.[2];Sophia Saad, Associate Editor - WikiDoc [3] Alejandro Lemor, M.D. [4] Template:Tuberculosis history and symptoms

Tuberculosis history and symptoms

Overview

This microchapter covers the clinical history and symptom presentation of tuberculosis (TB), including pulmonary and extrapulmonary disease, the WHO four-symptom screen for people with HIV, the concept of subclinical TB, and atypical presentations in special populations (HIV coinfection, children, elderly). It does not cover physical examination findings, diagnostic testing, imaging interpretation, or treatment.

Clinical history: What to ask

A focused history should establish pre-test probability (exposure plus host factors) and characterize the symptom pattern and duration.

• Epidemiologic risk: Close contact with a known infectious TB case, birth or prolonged residence in a high-incidence country, short-term travel to high-burden settings (particularly for healthcare workers or those visiting family), congregate living settings (shelters, correctional facilities), healthcare work in high-risk environments.
• Prior TB infection or treatment: Previous positive TST/IGRA, prior TB treatment (including incomplete courses, which raise concern for drug resistance).
• Immunosuppression and comorbidities: HIV status and CD4 count, use of TNF-α inhibitors, corticosteroids, or other immunosuppressive agents, organ transplantation, diabetes, chronic kidney disease, silicosis, malnutrition, smoking, and alcohol use—all of which increase risk of progression and may alter clinical presentation.

Pulmonary tuberculosis

Pulmonary TB accounts for approximately 70–80% of TB disease and typically presents as a subacute-to-chronic illness with symptoms evolving over weeks to months.

Common symptoms include:

• Cough — often persistent for >2–3 weeks; may progress from dry to productive
• Fever — often low-grade and intermittent
• Night sweats
• Unintentional weight loss and anorexia
• Hemoptysis — reported in approximately 20–30% of cases; ranges from blood-streaked sputum to massive hemoptysis (which may result from bronchial artery erosion or Rasmussen aneurysm)
• Pleuritic chest pain — may indicate pleural or subpleural involvement
• Dyspnea — typically reflects advanced/extensive parenchymal disease or large pleural effusion
• Fatigue and malaise

The combination of cough ≥2–3 weeks with constitutional symptoms (fever, night sweats, weight loss) in an appropriate epidemiologic context should prompt evaluation for TB. However, TB should be considered in any patient with a persistent unexplained cough, even in low-incidence settings, when risk factors are present.

WHO four-symptom screen (people with HIV)

The WHO four-symptom screen (W4SS) for active TB in people with HIV consists of: cough of any duration, fever, night sweats, and weight loss. The presence of any one symptom constitutes a positive screen.

In an individual participant data meta-analysis of 22 studies (n = 15,666):

• Not on ART: pooled sensitivity 85% (95% CI 76–91), specificity 37% (25–51)
• On ART: sensitivity 53% (35–71), specificity 71% (51–85)

Key clinical implications:

• The W4SS has substantially lower sensitivity in people on ART, making symptom-based screening alone insufficient in this population.
• C-reactive protein (≥10 mg/L) has comparable sensitivity to the W4SS but higher specificity, and is now included in WHO screening recommendations as an alternative or adjunct.
• Among severely immunosuppressed patients (CD4 <100 cells/μL), a negative W4SS does not exclude TB — systematic use of sputum Xpert and urine LAM testing regardless of symptoms improves case detection.

Subclinical tuberculosis

TB exists on a continuous spectrum from infection to subclinical disease to symptomatic disease. The International Consensus for Early TB (ICE-TB) framework (2024) defines subclinical TB as the presence of macroscopic pathology with viable Mycobacterium tuberculosis and an associated host response, but with symptoms/signs that are absent, unrecognized, or insufficient to prompt care-seeking.

Prevalence and significance:

• Among people with untreated HIV, subclinical TB prevalence ranges from 7% to 52%.
• National TB prevalence surveys have found that a median of 50% of bacteriologically confirmed TB cases did not report survey-specified screening symptoms (range 36–80%).
• An IPD meta-analysis of 12 national surveys (n = 602,863) found that up to 28% reported no TB-suggestive symptoms at all, while up to 83% reported no persistent cough (≥2 weeks).

Clinical relevance: Subclinical TB is microbiologically confirmed disease that is transmissible but would be missed by symptom-based case-finding alone. This has major implications for screening strategies, particularly in high-burden settings and among people with HIV.

Extrapulmonary tuberculosis (by site)

Extrapulmonary TB accounts for approximately 10–42% of TB disease, depending on immune status, age, and race/ethnicity. It is more common in people with HIV (especially with CD4 <200 cells/μL), young children, and other immunocompromised populations. Presentation typically includes constitutional symptoms (fever, night sweats, weight loss) plus site-specific manifestations. The subacute-to-chronic course and mimicry of malignancy or other infections necessitate a high index of suspicion.

Site	Key history/symptoms	Clinical notes
Pleural TB	Pleuritic chest pain, dyspnea, cough, fever; subacute onset over days to weeks	May coexist with pulmonary TB; isolated pleural TB may resolve spontaneously but carries high risk of subsequent reactivation at other sites if untreated
TB lymphadenitis	Painless, firm, non-tender lymphadenopathy (most often cervical); may become fluctuant and drain via sinus tract	Most common form of extrapulmonary TB; constitutional symptoms are more common in patients with HIV
TB meningitis	Subacute headache and fever evolving over days to weeks; prodrome of malaise, anorexia, and low-grade fever for 1–2 weeks; may progress to confusion, cranial nerve palsies (classically CN VI > III > IV > VII), seizures, and coma	Symptom duration >5 days helps distinguish from acute bacterial meningitis; MRC staging: I (GCS 15, no focal signs), II (GCS 11–14 or focal signs), III (GCS ≤10); urgent evaluation and early empiric therapy are critical
Skeletal TB (Pott disease)	Chronic back pain, stiffness, progressive spinal deformity; neurologic deficits from cord compression	Most commonly thoracic spine; insidious onset with often delayed diagnosis
Pericardial TB	Chest pain, dyspnea, cough, fever, night sweats, weight loss	Can present with acute effusion/tamponade or progress to constrictive pericarditis; more common in HIV-endemic settings
Genitourinary TB	Dysuria, hematuria, flank pain; infertility, pelvic pain, menstrual irregularity; scrotal mass	Often diagnosed late; sterile pyuria is a classic clue
Peritoneal/abdominal TB	Abdominal pain, distension, ascites, fever, weight loss	May mimic peritoneal carcinomatosis or inflammatory bowel disease
Laryngeal TB	Hoarseness, dysphagia, odynophagia, chronic cough	Highly infectious; frequently misdiagnosed as laryngeal carcinoma; may coexist with advanced pulmonary TB
Miliary/disseminated TB	Fever, weight loss, malaise; may present as sepsis-like syndrome with multi-organ dysfunction	More common in young children and severely immunosuppressed adults; mycobacteremia present in nearly half of hospitalized HIV-TB patients in high-burden settings

Atypical presentations and special populations

HIV coinfection

Clinical presentation varies with degree of immunosuppression:

• CD4 >200 cells/μL: Presentation resembles TB in HIV-negative patients — upper lobe infiltrates with or without cavitation, typical respiratory symptoms.
• CD4 <200 cells/μL: Atypical presentation is common — lower lobe or diffuse infiltrates without cavitation, hilar/mediastinal lymphadenopathy, extrapulmonary disease in up to 50% of cases. Cough may be absent.
• CD4 <75 cells/μL: Pulmonary findings may be absent entirely. Disseminated TB manifests as a nonspecific chronic febrile illness with widespread organ involvement and mycobacteremia. High early mortality; cases may be identified only at autopsy.

TB-IRIS (immune reconstitution inflammatory syndrome): After ART initiation, subclinical TB may unmask with pronounced inflammatory reactions at sites of infection.

A normal chest radiograph does not exclude pulmonary TB in advanced HIV — 8–29% of culture-positive cases may have a normal CXR.

Children

Clinical features of TB in children differ substantially from adults:

• Symptoms are often nonspecific and overlap with common pediatric conditions (pneumonia, HIV-associated lung disease, malnutrition): persistent cough, unexplained fever ≥1 week, failure to thrive or weight loss, fatigue, and decreased playfulness.
• Infants (<1 year): Highest risk of progression (up to 50%); high risk of disseminated and extrapulmonary disease (miliary TB, TB meningitis).
• Ages 1–4 years: Risk of disseminated disease is elevated (though lower than in infants); airway compression from exuberant lymph node response is common due to small, pliable airways.
• Ages 5–9 years: Lowest risk of progression in immunocompetent children; clinical manifestations may variably resemble either pediatric or adult-type disease.
• Ages ≥10 years: Adult-type pulmonary disease (upper lobe infiltrates, cavitation) becomes more common.
• TB meningitis is most common in children <3 years but can occur at any age, especially with HIV coinfection.

Elderly

TB in the elderly may present atypically:

• Classic symptoms (cough, fever, night sweats) may be blunted or absent.
• Presentation may mimic other common conditions (pneumonia, malignancy, failure to thrive).
• Lower lobe disease and atypical radiographic patterns are more common.
• Comorbidities and polypharmacy may mask symptoms or delay diagnosis.

Pregnant women

• The W4SS has even lower sensitivity in pregnant women with HIV (sensitivity ~28% in one study).
• TB in pregnancy may be mistaken for normal pregnancy-related symptoms (fatigue, weight change).

Clinically actionable recommendations

1. Evaluate for TB in any patient with cough ≥2–3 weeks plus constitutional symptoms in an appropriate epidemiologic context.
2. Do not exclude TB solely because of absent cough — disseminated, extrapulmonary, and subclinical TB may present without prominent respiratory symptoms, particularly in immunosuppressed patients.
3. Screen all people with HIV for TB using the W4SS at every clinical encounter; recognize its reduced sensitivity in those on ART and consider adjunctive screening tools (CXR, CRP, molecular diagnostics).
4. Maintain a high index of suspicion for extrapulmonary TB in patients with subacute constitutional symptoms plus site-specific findings, especially when immunosuppressed.
5. Urgently evaluate and empirically treat suspected TB meningitis given high mortality with delayed treatment.

High-yield clinical pearls

• Persistent cough ≥2–3 weeks with fever, night sweats, and weight loss is the classic presentation, but absence of any single symptom does not exclude TB.
• Hemoptysis occurs in ~20–30% and may be the presenting complaint; massive hemoptysis can occur from Rasmussen aneurysm.
• Sterile pyuria is a classic clue to genitourinary TB.
• 8–29% of culture-positive pulmonary TB in HIV has a normal CXR.
• TB meningitis has a subacute course (>5 days of symptoms); cranial nerve VI is classically the most commonly affected nerve.
• Subclinical TB accounts for a substantial proportion of bacteriologically confirmed cases and is transmissible — symptom-based screening alone will miss these cases.
• Laryngeal TB is highly infectious and frequently misdiagnosed as laryngeal carcinoma.

Common pitfalls

• Anchoring on cough: TB can present without cough, especially extrapulmonary and disseminated forms.
• Attributing symptoms to other diagnoses in immunosuppressed patients (e.g., PCP, lymphoma, other opportunistic infections) without considering TB.
• Over-reliance on the W4SS in patients on ART, where sensitivity is only ~53%.
• Dismissing TB with a normal CXR in HIV-positive patients.
• Delayed diagnosis of TB meningitis due to its insidious presentation — a high index of suspicion and early empiric therapy are essential.
• Underrecognizing TB in the elderly, where blunted symptoms and atypical radiographic patterns are common.
• Missing extrapulmonary TB that mimics malignancy (peritoneal carcinomatosis, lymphoma, laryngeal carcinoma).